SDC1 and breast carcinoma: Deletion of the C2 region of Sdc1 or the last 28 amino acids in the β4 integrin tail (Δ1728-1752), or mutation of R1733 within this sequence, abolishes the interaction, prevents tyrosine phosphorylation of the integrin and blocks epithelial cell migration on LN332 and breast carcinoma cell survival.